Coronary Calcification Doubted as a Good CV Risk Indicator

A meta-analysis of 10 trials that followed coronary artery calcification progression for at least one year found no consistent or reproducible effect of any therapy on CAC, suggesting CAC is not a good surrogate end point for trials of cardiovascular-disease therapies. Heartwire